Kirtland Hills Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$960K Sell
1,857
-69
-4% -$37.4K 0.3% 83
2025
Q4
$1.12M Buy
1,926
+33
+2% +$18.7K 0.39% 67
2025
Q3
$918K Sell
1,893
-106
-5% -$49.3K 0.36% 81
2025
Q2
$811K Buy
1,999
+81
+4% +$33.9K 0.37% 81
2025
Q1
$820K Sell
1,918
-301
-14% -$163K 0.5% 65
2024
Q4
$1.15M Buy
2,219
+39
+2% +$21.4K 0.74% 46
2024
Q3
$1.35M Buy
2,180
+209
+11% +$124K 0.74% 36
2024
Q2
$1.09M Buy
1,971
+27
+1% +$15.5K 0.91% 35
2024
Q1
$1.12M Buy
+1,944
New +$1.09M 0.96% 33

Other funds holding TMO

Kirtland Hills Capital Management's TMO Position: Q1 2026 in Review

Kirtland Hills Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 3.6% in Q1 2026, selling an estimated $37.4K and leaving 1,857 shares worth $960K. The position accounts for 0.3% of the portfolio, ranked #83.

Kirtland Hills Capital Management first reported a position in TMO in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.35M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Kirtland Hills Capital Management held 1,857 shares of Thermo Fisher Scientific worth $960K as of Q1 2026.
  • Kirtland Hills Capital Management sold 69 Thermo Fisher Scientific shares in Q1 2026, an estimated $37.4K.
  • Thermo Fisher Scientific made up 0.3% of Kirtland Hills Capital Management's portfolio in Q1 2026, its #83 holding.
  • Kirtland Hills Capital Management first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 9 quarters since.
  • Kirtland Hills Capital Management's Thermo Fisher Scientific position peaked at $1.35M in Q3 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Kirtland Hills Capital Management's 13F filing for Q1 2026, filed 13 May 2026.